New to posting on this board. Have been reading everyone's posts for about six months. I must say this is one of the most knowledgeable groups of people I have run across on the internet.
Just wondering if anyone else had heard of using Avodart(dutasteride) once monthly for hair loss prevention?
This was suggested to me by a physician friend of mine. It seems plausable but wondering if anyone has real world feedback.
Thanks
Auspex
Here is some info from Micromedix I found:
AVODART
.2 DURATION
A. SINGLE DOSE:
1. PLASMA DIHYDROTESTOSTERONE REDUCTIONS, ORAL: 3 to 8 weeks (healthy subjects) (Olsson Gisleskog et al, 1998).
a. Time of sustained decreases in plasma 5-alpha-dihydrotestosterone (DHT) levels after single oral doses of 1 to 40 mg in healthy subjects; duration of DHT suppression was dose-related.
2.3.5 HALF-LIFE
2.3.5.1 PARENT COMPOUND
A. ELIMINATION HALF-LIFE: up to 5 weeks (Olsson Gisleskog et al, 1999; (Prod Info Avodart(TM), 2004).
A. MECHANISM OF ACTION
1. Dutasteride is a dual 5-alpha-reductase inhibitor indicated for the treatment of benign prostatic hyperplasia (BPH) (Anon, 2001; Olsson Gisleskog et al, 1998). The 5-alpha-reductase enzyme is responsible for converting testosterone to 5-alpha-dihydrotestosterone (DHT), which is considered primarily responsible for signs/symptoms of BPH (Olsson Gisleskog et al, 1998; Makridakis et al, 2000). Two isozymes of 5-alpha-reductase are present in humans, type 1 (mainly in liver and skin) and type 2 (predominant form in the prostate) (Olsson Gisleskog et al, 1999; Olsson Gisleskog et al, 1998).
2. Enzymologic studies have demonstrated that dutasteride is an irreversible competitive inhibitor of 5-alpha-reductase types 1 and 2, which results in significant reductions in circulating DHT levels (Olsson Gisleskog et al, 1998; Olsson Gisleskog et al, 1999a). Data from animal studies have suggested that dutasteride is more potent than finasteride, a selective and irreversible 5-alpha-reductase type 2 inhibitor; greater falls in DHT concentrations were observed with dutasteride (Olsson Gisleskog et al, 1998; Olsson Gisleskog et al, 1999).
3. In healthy subjects (Olsson Gisleskog et al, 1998), dutasteride in single oral doses of 1 milligram (mg) or higher reduced DHT concentrations by 70 to 95%, with levels remaining decreased for 3 to 8 weeks; the degree and duration of DHT suppression were dose-related. After oral finasteride 5 mg, DHT levels were suppressed by approximately 80%, and the duration of suppression was shorter (1 to 2 weeks). This study indicated that the potency of dutasteride was about 3-fold that of finasteride for inhibition of 5-alpha-reductase type 2. Near-full blockade of both isozymes occurred with dutasteride 10 mg or greater
Just wondering if anyone else had heard of using Avodart(dutasteride) once monthly for hair loss prevention?
This was suggested to me by a physician friend of mine. It seems plausable but wondering if anyone has real world feedback.
Thanks
Auspex
Here is some info from Micromedix I found:
AVODART
.2 DURATION
A. SINGLE DOSE:
1. PLASMA DIHYDROTESTOSTERONE REDUCTIONS, ORAL: 3 to 8 weeks (healthy subjects) (Olsson Gisleskog et al, 1998).
a. Time of sustained decreases in plasma 5-alpha-dihydrotestosterone (DHT) levels after single oral doses of 1 to 40 mg in healthy subjects; duration of DHT suppression was dose-related.
2.3.5 HALF-LIFE
2.3.5.1 PARENT COMPOUND
A. ELIMINATION HALF-LIFE: up to 5 weeks (Olsson Gisleskog et al, 1999; (Prod Info Avodart(TM), 2004).
A. MECHANISM OF ACTION
1. Dutasteride is a dual 5-alpha-reductase inhibitor indicated for the treatment of benign prostatic hyperplasia (BPH) (Anon, 2001; Olsson Gisleskog et al, 1998). The 5-alpha-reductase enzyme is responsible for converting testosterone to 5-alpha-dihydrotestosterone (DHT), which is considered primarily responsible for signs/symptoms of BPH (Olsson Gisleskog et al, 1998; Makridakis et al, 2000). Two isozymes of 5-alpha-reductase are present in humans, type 1 (mainly in liver and skin) and type 2 (predominant form in the prostate) (Olsson Gisleskog et al, 1999; Olsson Gisleskog et al, 1998).
2. Enzymologic studies have demonstrated that dutasteride is an irreversible competitive inhibitor of 5-alpha-reductase types 1 and 2, which results in significant reductions in circulating DHT levels (Olsson Gisleskog et al, 1998; Olsson Gisleskog et al, 1999a). Data from animal studies have suggested that dutasteride is more potent than finasteride, a selective and irreversible 5-alpha-reductase type 2 inhibitor; greater falls in DHT concentrations were observed with dutasteride (Olsson Gisleskog et al, 1998; Olsson Gisleskog et al, 1999).
3. In healthy subjects (Olsson Gisleskog et al, 1998), dutasteride in single oral doses of 1 milligram (mg) or higher reduced DHT concentrations by 70 to 95%, with levels remaining decreased for 3 to 8 weeks; the degree and duration of DHT suppression were dose-related. After oral finasteride 5 mg, DHT levels were suppressed by approximately 80%, and the duration of suppression was shorter (1 to 2 weeks). This study indicated that the potency of dutasteride was about 3-fold that of finasteride for inhibition of 5-alpha-reductase type 2. Near-full blockade of both isozymes occurred with dutasteride 10 mg or greater